Is Comprehensive Genomic Profiling Ready for Prime Time?
Next-generation genome analysis technologies allow for the sequencing of multiple genes at once to characterize the mutational profile of...
Next-generation genome analysis technologies allow for the sequencing of multiple genes at once to characterize the mutational profile of...
Cancer treatments have been, and continue to be in most cases, based on the organ site where the tumor...
AACR Project Genomics Evidence Neoplasia Information Exchange (GENIE) recently hit another milestone: the public release of a fourth dataset,...
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today Do cancer cells have Achilles’ heels? The answer...
Prostate cancer is one of the most common cancers diagnosed in the United States. About one-third of men diagnosed...
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today
Guest Post by Charles L. Sawyers, MD AACR Project GENIE Steering Committee Chairperson
Conference co-chair Elaine R. Mardis, PhD, discusses the third conference in the AACR's Precision Medicine Series, “Integrating Clinical Genomics...
When the hottest minds in cancer genomics meet the hottest minds in computational and systems biology, you can rest...
Big progress was made in 2014, in the form of FDA approvals for new immunotherapies, targeted therapies, and a...